• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术肺活检后间质性肺病的手术量和死亡率。

Procedure volume and mortality after surgical lung biopsy in interstitial lung disease.

机构信息

Dept of Medicine, University of Toronto, Toronto, ON, Canada.

Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.

出版信息

Eur Respir J. 2019 Feb 21;53(2). doi: 10.1183/13993003.01164-2018. Print 2019 Feb.

DOI:10.1183/13993003.01164-2018
PMID:30487208
Abstract

Surgical volume-outcome relationships are well established but have not been studied in patients with interstitial lung disease (ILD) undergoing surgical lung biopsy (SLB). Our study objective was to determine if hospital SLB volume is associated with post-operative mortality in patients with ILD.A cohort study using administrative, population-based data from Ontario, Canada was performed in adults with ILD who underwent a SLB between 2001 and 2014. The association between yearly hospital SLB volume and 30-day post-operative mortality was assessed using multilevel logistic regression modelling.3057 surgical lung biopsies for ILD were performed during the study period with a median (interquartile range) yearly hospital volume of 73 (34-143) procedures. 30-day mortality was 7.1%, 20.2% and 1.9% in overall, nonelective and elective patients, respectively. Higher yearly hospital SLB volume was associated with lower odds of 30-day post-operative mortality after adjusting for patient characteristics (OR 0.84, 95% CI 0.73-0.97; p=0.02), with the association appearing stronger for nonelective elective procedures (OR 0.84, 95% CI 0.69-1.02; p=0.08 OR 0.94, 95% CI 0.74-1.18; p=0.57).Higher yearly hospital SLB volume was associated with lower post-operative mortality in patients with ILD, with the association appearing to be mainly driven by nonelective cases. SLB mortality was significantly higher for nonelective cases.

摘要

手术量-结局关系已经得到充分证实,但尚未在接受外科肺活检 (SLB) 的间质性肺疾病 (ILD) 患者中进行研究。我们的研究目的是确定ILD 患者的医院 SLB 量是否与术后死亡率相关。

本研究采用加拿大安大略省的行政、人群为基础的数据进行了一项队列研究,研究对象为 2001 年至 2014 年间接受 SLB 的ILD 成人患者。使用多水平逻辑回归模型评估了每年医院 SLB 量与 30 天术后死亡率之间的关联。

在研究期间,对 3057 例ILD 进行了外科肺活检,中位数(四分位间距)每年医院手术量为 73 例(34-143 例)。总体而言,所有患者、非选择性患者和选择性患者的 30 天死亡率分别为 7.1%、20.2%和 1.9%。在校正患者特征后,较高的每年医院 SLB 量与较低的 30 天术后死亡率相关(OR 0.84,95%CI 0.73-0.97;p=0.02),非选择性和选择性手术的相关性更强(OR 0.84,95%CI 0.69-1.02;p=0.08 OR 0.94,95%CI 0.74-1.18;p=0.57)。

在ILD 患者中,较高的每年医院 SLB 量与较低的术后死亡率相关,且该关联似乎主要由非选择性病例驱动。非选择性病例的 SLB 死亡率明显更高。

相似文献

1
Procedure volume and mortality after surgical lung biopsy in interstitial lung disease.手术肺活检后间质性肺病的手术量和死亡率。
Eur Respir J. 2019 Feb 21;53(2). doi: 10.1183/13993003.01164-2018. Print 2019 Feb.
2
The role of surgical lung biopsy in the management of interstitial lung disease: experience from a single institution in the UK.外科肺活检在间质性肺疾病管理中的作用:来自英国一家机构的经验。
Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):253-7. doi: 10.1093/icvts/ivt217. Epub 2013 May 14.
3
Outcomes and safety of surgical lung biopsy for interstitial lung disease.间质性肺疾病外科肺活检的结果与安全性
Chest. 2005 May;127(5):1600-5. doi: 10.1378/chest.127.5.1600.
4
Surgical lung biopsies in 418 patients with suspected interstitial lung disease in China.中国418例疑似间质性肺疾病患者的外科肺活检。
Intern Med. 2010;49(12):1097-102. doi: 10.2169/internalmedicine.49.3225. Epub 2010 Jun 15.
5
Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy.手术肺活检用于间质性疾病的疗效与安全性。来自意大利一家机构的161例连续患者的经验。
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):251-8.
6
Do the number and volume of surgical lung biopsies influence the diagnostic yield in interstitial lung disease? A propensity score analysis.外科肺活检的数量和体积是否会影响间质性肺疾病的诊断率?一项倾向评分分析。
Arch Bronconeumol. 2015 Feb;51(2):76-79. doi: 10.1016/j.arbres.2014.05.011. Epub 2014 Oct 11.
7
Outcomes Following Surgical Lung Biopsy for Interstitial Lung Diseases: A Monocenter Experience.外科肺活检治疗间质性肺疾病的结果:单中心经验。
Thorac Cardiovasc Surg. 2022 Oct;70(7):583-588. doi: 10.1055/s-0041-1740548. Epub 2022 Feb 12.
8
Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease.经支气管肺活检与外科肺活检在疑似纤维化间质性肺疾病诊断中的效用
Chest. 2017 Feb;151(2):389-399. doi: 10.1016/j.chest.2016.09.028. Epub 2016 Oct 8.
9
Aggregate risk score for predicting mortality after surgical biopsy for interstitial lung disease.预测间质性肺疾病手术活检后死亡率的综合风险评分。
Interact Cardiovasc Thorac Surg. 2012 Aug;15(2):276-9. doi: 10.1093/icvts/ivs174. Epub 2012 May 17.
10
A single-institution study of concordance of pathological diagnoses for interstitial lung diseases between pre-transplantation surgical lung biopsies and lung explants.一项单中心研究,探讨了移植前外科肺活检和肺移植标本之间间质性肺疾病的病理诊断一致性。
BMC Pulm Med. 2019 Jan 21;19(1):20. doi: 10.1186/s12890-019-0778-x.

引用本文的文献

1
Diagnosis of early idiopathic pulmonary fibrosis: current status and future perspective.早期特发性肺纤维化的诊断:现状与未来展望
Respir Res. 2025 May 19;26(1):192. doi: 10.1186/s12931-025-03270-1.
2
Updates in Diagnostic Tools for ILD.间质性肺疾病诊断工具的更新
J Clin Med. 2025 Apr 24;14(9):2924. doi: 10.3390/jcm14092924.
3
Comprehensive Strategies for Preoperative Pulmonary Risk Evaluation and Management.术前肺风险评估与管理的综合策略
Tuberc Respir Dis (Seoul). 2025 Jan;88(1):90-108. doi: 10.4046/trd.2024.0118. Epub 2024 Oct 30.
4
Acute exacerbation of interstitial lung diseases and mortality post-cryobiopsy: a multicenter cohort study.间质性肺疾病急性加重与冷冻活检后的死亡率:一项多中心队列研究
J Thorac Dis. 2024 Jul 30;16(7):4340-4349. doi: 10.21037/jtd-24-270. Epub 2024 Jul 22.
5
A nitroreductase responsive probe for early diagnosis of pulmonary fibrosis disease.一种用于肺纤维化疾病早期诊断的硝基还原酶响应探针。
Redox Biol. 2024 Sep;75:103294. doi: 10.1016/j.redox.2024.103294. Epub 2024 Jul 29.
6
Correlation of CT-based radiomics analysis with pathological cellular infiltration in fibrosing interstitial lung diseases.基于 CT 的放射组学分析与纤维性肺间质疾病中病理性细胞浸润的相关性。
Jpn J Radiol. 2024 Oct;42(10):1157-1167. doi: 10.1007/s11604-024-01607-2. Epub 2024 Jun 18.
7
Assessment of a randomized controlled trial on the safety of pre-placing bronchial balloons in transbronchial lung cryobiopsy for diagnosing interstitial lung disease.评估经支气管肺冷冻活检术诊断间质性肺疾病中预先放置支气管球囊的安全性的随机对照试验。
Eur J Med Res. 2024 May 3;29(1):268. doi: 10.1186/s40001-024-01871-y.
8
Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist's Key Role.多学科方法诊断特发性间质性肺炎:关注病理学家的关键作用。
Int J Mol Sci. 2024 Mar 23;25(7):3618. doi: 10.3390/ijms25073618.
9
Diagnosis and Pharmacologic Management of Fibrotic Interstitial Lung Disease.纤维化间质性肺疾病的诊断与药物治疗
Life (Basel). 2023 Feb 21;13(3):599. doi: 10.3390/life13030599.
10
Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.观点:一种多学科方法评估系统性硬化症相关间质性肺疾病患者。
Clin Rheumatol. 2023 Mar;42(3):653-661. doi: 10.1007/s10067-022-06408-4. Epub 2022 Oct 21.